Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Cai, Nan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study - Ha, Diep H ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:26 ; year:2016 ; pages:309-318 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jff.2016.08.014 |
|---|
| Katalog-ID: |
ELV024386898 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV024386898 | ||
| 003 | DE-627 | ||
| 005 | 20230623173736.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jff.2016.08.014 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016009000004.pica |
| 035 | |a (DE-627)ELV024386898 | ||
| 035 | |a (ELSEVIER)S1756-4646(16)30224-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 630 |a 640 |a 610 | |
| 082 | 0 | 4 | |a 630 |q DE-600 |
| 082 | 0 | 4 | |a 640 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.96 |2 bkl | ||
| 100 | 1 | |a Cai, Nan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| 264 | 1 | |c 2016 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. | ||
| 700 | 1 | |a Xie, Shu-Juan |4 oth | |
| 700 | 1 | |a Qiu, Dong-Bo |4 oth | |
| 700 | 1 | |a Jia, Chang-Chang |4 oth | |
| 700 | 1 | |a Du, Cong |4 oth | |
| 700 | 1 | |a Liu, Wei |4 oth | |
| 700 | 1 | |a Chen, Jia-Jie |4 oth | |
| 700 | 1 | |a Zhang, Qi |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Ha, Diep H ELSEVIER |t Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV007989776 |
| 773 | 1 | 8 | |g volume:26 |g year:2016 |g pages:309-318 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jff.2016.08.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.96 |j Zahnmedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 26 |j 2016 |h 309-318 |g 10 | ||
| 953 | |2 045F |a 630 | ||
| author_variant |
n c nc |
|---|---|
| matchkey_str |
cainanxieshujuanqiudongbojiachangchangdu:2016----:oetaefcsfagsiitervninntetetf |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.96 |
| publishDate |
2016 |
| allfields |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
| spelling |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
| allfields_unstemmed |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
| allfieldsGer |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
| allfieldsSound |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
| language |
English |
| source |
Enthalten in Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study Amsterdam [u.a.] volume:26 year:2016 pages:309-318 extent:10 |
| sourceStr |
Enthalten in Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study Amsterdam [u.a.] volume:26 year:2016 pages:309-318 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Zahnmedizin |
| institution |
findex.gbv.de |
| dewey-raw |
630 |
| isfreeaccess_bool |
false |
| container_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
| authorswithroles_txt_mv |
Cai, Nan @@aut@@ Xie, Shu-Juan @@oth@@ Qiu, Dong-Bo @@oth@@ Jia, Chang-Chang @@oth@@ Du, Cong @@oth@@ Liu, Wei @@oth@@ Chen, Jia-Jie @@oth@@ Zhang, Qi @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007989776 |
| dewey-sort |
3630 |
| id |
ELV024386898 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024386898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623173736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jff.2016.08.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016009000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024386898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1756-4646(16)30224-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.96</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cai, Nan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Shu-Juan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Dong-Bo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jia, Chang-Chang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Du, Cong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jia-Jie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Ha, Diep H ELSEVIER</subfield><subfield code="t">Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007989776</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:309-318</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jff.2016.08.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.96</subfield><subfield code="j">Zahnmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2016</subfield><subfield code="h">309-318</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">630</subfield></datafield></record></collection>
|
| author |
Cai, Nan |
| spellingShingle |
Cai, Nan ddc 630 ddc 640 ddc 610 bkl 44.96 Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| authorStr |
Cai, Nan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007989776 |
| format |
electronic Article |
| dewey-ones |
630 - Agriculture & related technologies 640 - Home & family management 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| topic |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
| topic_unstemmed |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
| topic_browse |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s j x sjx d b q dbq c c j ccj c d cd w l wl j j c jjc q z qz |
| hierarchy_parent_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
| hierarchy_parent_id |
ELV007989776 |
| dewey-tens |
630 - Agriculture 640 - Home & family management 610 - Medicine & health |
| hierarchy_top_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007989776 |
| title |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| ctrlnum |
(DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 |
| title_full |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| author_sort |
Cai, Nan |
| journal |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
| journalStr |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
309 |
| author_browse |
Cai, Nan |
| container_volume |
26 |
| physical |
10 |
| class |
630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Cai, Nan |
| doi_str_mv |
10.1016/j.jff.2016.08.014 |
| dewey-full |
630 640 610 |
| title_sort |
potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| title_auth |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| abstract |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
| abstractGer |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
| abstract_unstemmed |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
| url |
https://doi.org/10.1016/j.jff.2016.08.014 |
| remote_bool |
true |
| author2 |
Xie, Shu-Juan Qiu, Dong-Bo Jia, Chang-Chang Du, Cong Liu, Wei Chen, Jia-Jie Zhang, Qi |
| author2Str |
Xie, Shu-Juan Qiu, Dong-Bo Jia, Chang-Chang Du, Cong Liu, Wei Chen, Jia-Jie Zhang, Qi |
| ppnlink |
ELV007989776 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jff.2016.08.014 |
| up_date |
2024-07-06T21:18:03.397Z |
| _version_ |
1803866009394741248 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024386898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623173736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jff.2016.08.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016009000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024386898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1756-4646(16)30224-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.96</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cai, Nan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Shu-Juan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Dong-Bo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jia, Chang-Chang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Du, Cong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jia-Jie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Ha, Diep H ELSEVIER</subfield><subfield code="t">Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007989776</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:309-318</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jff.2016.08.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.96</subfield><subfield code="j">Zahnmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2016</subfield><subfield code="h">309-318</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">630</subfield></datafield></record></collection>
|
| score |
7.3994865 |